Skip to content

Banxia-Xiexin-Decoction-based sequential therapy for Helicobacter pylori infection eradication: a real-world study

Banxia-Xiexin-Decoction-based sequential therapy for Helicobacter pylori infection eradication: a real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2000003473
Enrollment
Unknown
Registered
2020-07-07
Start date
2020-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hp infection

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria; (2) Aged 18-70 years; (3) Actively cooperated with the treatment and willing to accept the follow-up visit as the observation objects; (4) Did not take any drugs related to the treatment effect of this study within 4 weeks before the start of the observation.

Exclusion criteria

Exclusion criteria: (1) Patients who had HP eradication treatment within 6 months; (2) patients with gastrointestinal ulcer indicated by endoscopy; (3) patients with liver and kidney dysfunction, severe cardiovascular and cerebrovascular diseases, and malignant tumor diseases; (4) those who were definitely diagnosed with mental disorders, speech and behavior disorders; (5) pregnant or lactating women; (6) patients with drug allergy history; (7) patients with liver and kidney dysfunction and severe cardiovascular and cerebrovascular diseases and malignant tumor diseases Participants or participants in other drug trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
C-13 breath test;

Secondary

MeasureTime frame
Symptom score;

Countries

China

Contacts

Public ContactJianghong Ling

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

459183870@qq.com+86 18817424778

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026